Mehdi Touat

26PUBLICATIONS
238CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 12, 2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|Apr 01, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.

Capucine Baldini, Philippe A Cassier, Jean-Pierre Delord

|Mar 09, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases.

Mehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

Pageof 5

Frequent Collaborators

8 joint publications

Patrick Y Wen

7 joint publications

David A Reardon

6 joint publications

Keith L Ligon

5 joint publications

Ahmed Idbaih